Global Digital Therapeutics Market is Anticipated to Reach US$ 9,121.8 by 2027, Growing at an Estimated CAGR of 21.1% Over the Forecast Period, Owing to Rising Concern For Cardiovascular Diseases in Both Developed and Emerging Economies, Says Absolute Markets Insights.

Pune, India -- (SBWire) -- 03/15/2019 --Cardiovascular disease condition consists of high blood pressure, coronary heart disease, stroke, congestive heart failure and atrial fibrillation. In 2015, it has been reported that 102.7 million people in the United States suffered from of the above mentioned disease. By 2035, the number is expected to rise by 45% i.e., 131.2 million Americans, out of total United States population. Being able to monitor someone on a regular basis and keeping an eye onto key physiological parameter such as heart rate or blood pressure could prevent an acute cardiovascular event. Here comes the digital therapeutics market application, wherein a person can effectively prevent himself/herself from any cardiovascular disease. Such an initiative is actively adopted by both consumers and physicians, which in turn will aid the overall digital therapeutic market to grow in 2019.

Withings is focused on making digital products for physiological monitoring. The company obtained FDA approval for a wireless blood pressure cuff, used along with an app to display blood pressure data. The historic readings are duly saved in cloud and can be used by either patient or physician to note changes from previous references.

Request a Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=199

Along with Withings, iHealth Lab based in California is engaged in selling wireless products that measure physiology. The company developed a blood pressure monitor that is usually placed on the wrist. The data is then sent to an app and can be displayed in mobile device. Both the monitoring devices has received FDA clearance. Such digital initiatives by various industry participants is expected to drive the global digital therapeutics market over the forecast period. Wearable devices such as Microsoft Band, Fitbit fitness tracker and Apple Watch exhibit variety of functions such as distance traveled, calorie counting and heart rate measurement. Also, digital health tools allows the practitioner to monitor a patient's atrial fibrillation (AFib) symptoms between visits and provides point-of-service medications. Heal Force, a China based company is engaged in providing a fully automatic digital blood pressure measuring device used by adults on the upper arm either at office or home. Factors such as one button operation, high capacity data storage, large LCD display amongst other makes the device more compatible in nature. Rossmax International Ltd. which has its locations in China, India, Japan amongst others, is engaged in providing devices pertained to prevention, monitoring, therapy and professional business segments.

"Digital Therapeutics – Just the beginning! The industry participants involved in providing devices and software in digital therapeutics market have set the initial stage and is waiting to earn incredible reputation & credibility with evidence based results."

The detailed research study provides qualitative and quantitative analysis of the global digital therapeutics market. The market has been analyzed from demand as well as supply side. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Some of the major players operating in the global digital therapeutics market are BLUE MESA HEALTH, CANARY HEALTH, Chrono Therapeutics Inc., Adherium, BigHealth, Diabetes Digital Media Ltd, Digital Therapeutics, Inc., Dthera Sciences, MANGO HEALTH, Merck & Co., Inc., Firstbeat, GINGER.IO, Glooko, Inc., Limbix , Livongo Health, Noom, Inc., Novartis AG, Omada Health, Inc., Proteus Digital Health, WellDoc, Inc., Propeller Health among others.

Inquiry Before Buying This Report@ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=199

By Products

o Software
o Devices

By Application

o Cardiovascular Diseases
o Central Nervous System (CNS) Disease
o Diabetes
o Gastrointestinal Disorders (GID)
o Mental Health
o Neurology
o Obesity
o Ophthalmology
o Respiratory Diseases
o Smoking Cessation
o Others

By Distribution Channel

o Business to Business
o Business to Customer

By End User

o Patients
o Healthcare Providers
o Payers
o Employers
o Other (Fitness and Wellness Centers, Gym, Etc.)

By Geography

North America
o U.S.
o Canada
o Mexico
o Rest of North America

Europe
o France
o The UK
o Spain
o Germany
o Italy
o Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
o Benelux Union
- Belgium
- The Netherlands
- Luxembourg
o Rest of Europe

Asia Pacific

o China
o Japan
o India
o Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific

Middle East & Africa

o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa

Latin America

o Brazil
o Argentina
o Rest of Latin America